1.Briggs, DJ (2012) The role of vaccination in rabies prevention. Current Opinions in Virology 2, 309–314.
2.Gaskell, RM, Dawson, S and Radford, AD (2006) Duration of immunity (DOI)—the regulatory issues. Veterinary Microbiology 117, 80–85.
3.Hartmann, K, et al. (2015) Feline injection-site sarcoma: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 17, 606–13.
4.Scott, FW and Geissinger, CM (1999) Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. American Journal of Veterinary Research 60, 652–8.
5.Lakshmanan, N, et al. (2006) Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus. Veterinary Therapeutics 7, 223–31.
6.Jas, D, et al. (2015) Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial. Veterinary Microbiology 177, 123–31.
7.Day, MJ, et al. (2016) Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). WSAVA Guidelines for the vaccination of dogs and cats. Journal of Small Animal Practice 57, E1–E45.
8.Hosie, MJ, et al. (2015) Matrix vaccination guidelines. Journal of Feline Medicine and Surgery 17, 583–587.
9.Richards, JR, et al. (2006) The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report. Journal of the American Veterinary Medical Association 229, 1405–41.
10.Day, MJ, et al. (2016) WSAVA Guidelines for the vaccination of dogs and cats. Journal of Small Animal Practice 57, E1–E45.
11.Asher, L, et al. (2011) Estimation of the number and demographics of companion dogs in the UK. BMC Veterinary Research 7, 74.
12.Murray, JK and Gruffydd-Jones, TJ (2012) Proportion of pet cats registered with a veterinary practice and factors influencing registration in the UK. Veterinary Journal 192, 461–466.
13.Sánchez-Vizcaíno, F, et al. (2015) Small animal disease surveillance. Veterinary Record 177, 591–594.
14.Sánchez-Vizcaíno, F, et al. (2017) Demographics of dogs, cats, and rabbits attending veterinary practices in Great Britain as recorded in their electronic health records. BMC Veterinary Research 13, 218.
17.Robinson, NJ, et al. (2016) Investigating preventive-medicine consultations in first-opinion small-animal practice in the United Kingdom using direct observation. Preventive Veterinary Medicine 124, 69–77.
19.Jain, A, et al. (2017) Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake. Vaccine 35, 2315–2328.
20.Hungerford, D, et al. (2016) Effect of socioeconomic deprivation on uptake of measles, mumps and rubella vaccination in Liverpool, UK over 16 years: a longitudinal ecological study. Epidemiology and Infection. 144, 1201–11.
21.Habacher, G, Gruffydd-Jones, T and Murray, J (2010) Use of a web-based questionnaire to explore cat owners’ attitudes towards vaccination in cats. Veterinary Record 167, 122–7.
22.Schultz, RD (2006) Duration of immunity for canine and feline vaccines: A review. Veterinary Microbiology 117, 75–79.
23.Day, MJ, Horzinek, MC and Schultz, RD (2007) Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). Journal of Small Animal Practice 48, 528–41.
24.Abdelmagid, OY, et al. (2004) Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges. Veterinary Therapeutics 5, 173–86.
25.Gore, TC, et al. (2005) Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus. Veterinary Therapeutics 6, 5–14.
26.Hou, J, et al. (2016) European molecular epidemiology and strain diversity of feline calicivirus. Veterinary Record 178, 114–5.
27.Porter, CJ, et al. (2008) Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates. Journal of Feline Medicine and Surgery 10, 32–40.
28.Addie, D, et al. (2008) Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK. Veterinary Record 163, 355–7.
29.Afonso, MM, et al. (2017) A multi-national European cross-sectional study of feline calicivirus epidemiology, diversity and vaccine cross-reactivity. Vaccine 35, 2753–2760.
30.Gaskell, R, et al. (2007) Feline herpesvirus. Veterinary Research 38, 337–54.
31.Radford, AD, et al. (2009) Feline calicivirus infection: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 11, 556–564.
32.Thiry, E, et al. (2009) Feline herpesvirus infection: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 11, 547–555.
33.Lutz, H, et al. (2009) Feline leukaemia. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 11, 565–74.
34.Gaskell, RM, et al. (2002) Veterinary Products Committee working group report on feline and canine vaccination. Veterinary Record 150, 126–34.
35.Mochizuki, M, et al. (2008) Etiologic study of upper respiratory infections of household dogs. Journal of Veterinary Medical Sciences 70, 563–9.
36.Decaro, N, et al. (2016) Molecular surveillance of traditional and emerging pathogens associated with canine infectious respiratory disease. Veterinary Microbiology 192, 21–25.
37.Helps, CR, et al. (2005) Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Veterinary Record 156, 669–73.
38.Binns, SH, et al. (1999) Prevalence and risk factors for feline Bordetella bronchiseptica infection. Veterinary Record 144, 575–80.